{"id":"W2304373741","doi":"10.1097/jto.0000000000000693","title":"Monotherapy Administration of Sorafenib in Patients With Non–Small Cell Lung Cancer (MISSION) Trial","year":2015,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Sorafenib; Internal medicine; Hazard ratio; Placebo; Lung cancer; Gastroenterology; Clinical endpoint; Oncology; Progression-free survival; Confidence interval; Randomized controlled trial; Hepatocellular carcinoma; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002270536,0.00008732997,0.0003822892,0.0001516698,0.00001507247,0.000004638079,0.00005501093,0.000090118,0.00005033309],"category_scores_gemma":[0.00002625618,0.0000562444,0.00005748204,0.0001334129,0.00002685683,0.00008730152,0.000006063994,0.0001550285,8.296863e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004730903,"about_ca_system_score_gemma":0.002448705,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004186635,"about_ca_topic_score_gemma":0.00005471852,"domain_scores_codex":[0.9990809,0.00006821469,0.000445427,0.00008530686,0.0002098503,0.000110333],"domain_scores_gemma":[0.9987568,0.00003666882,0.0005839288,0.00008844231,0.0003892294,0.0001449234],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4814672,0.007507493,0.3945925,0.0001844569,0.0005484626,0.0002999891,0.004748909,0.0006030169,0.0005930015,0.000008625774,0.00309119,0.1063552],"study_design_scores_gemma":[0.4659157,0.1035911,0.3869406,0.001213204,0.00366893,0.0001486514,0.002049515,0.0004692186,0.01254291,0.0001827385,0.02282494,0.0004524988],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961455,0.0003200314,0.0001992557,0.001081737,0.0004443658,0.0005062238,0.000005268823,0.000002611941,0.001295011],"genre_scores_gemma":[0.9962977,0.00004136895,0.002881275,0.0001289029,0.0001953456,0.00001043972,0.000006938835,0.00001168696,0.0004264073],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1059027,"threshold_uncertainty_score":0.4343898,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02768786980656785,"score_gpt":0.4436823993396465,"score_spread":0.4159945295330786,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}